AAV1-CAG-EGFP (#7071)* Deliverable: purified AAV stock* Buffer: PBS/0.001% PF-68/5% glycerol*… and 2 more items

Vector Biolabs has been awarded a contract by the University of Virginia under award number A207_PO-0461011, effective July 22, 2026, for the provision of adeno-associated virus (AAV) products and related delivery services. The contract is valued at $1,282.80. The primary deliverables consist of two purified AAV stock preparations: AAV1-CAG-EGFP (catalog #7071) and AAV9-CAG-EGFP (catalog #7076), each supplied in a 50-microliter volume at a quantitative polymerase chain reaction (qPCR) titer of 1x10^13 genome copies per milliliter, buffered in phosphate-buffered saline with 0.001% Pluronic F-68 and 5% glycerol. Both viral preparations are priced at $626.40 each. The contract also includes a dry ice fee of $30.00 for shipping purposes.

Delivery of the AAV1 preparation is anticipated within 3 to 4 weeks, while the AAV9 preparation is expected within 1 to 2 weeks from the award date. All deliverables are consigned to Stef Gunst at the University of Virginia in Virginia. These products are commonly utilized in research applications requiring viral vector-mediated gene delivery, with the specified envelope proteins enabling differential tissue tropism for experimental purposes.